Posts Tagged ‘cardiomyopathy’

A Long Term Follow-up Study of Carriers of Hypertrophic Cardiomyopathy Mutations

Adults who test positive for a mutation associated with the development of hypertrophic cardiomyopathy (HCM) but who have not manifested left ventricular hypertrophy (LVH) at the time of that diagnosis are now commonly identified in the era of genetic testing. There are little published data, however, on the long-term outlook for these phenotypically normal gene carriers.

McTaggart DR, et al. A Long Term Follow-up Study of Carriers of Hypertrophic
Cardiomyopathy Mutations. Heart, Lung and Circulation (2016), http://dx.doi.org/10.1016/j.hlc.2016.04.019

Clinical characteristics and outcomes of patients with P-associated cardiomyopathy (PAC) in Auckland, New Zealand

Methamphetamine or P-associated cardiomyopathy (PAC) is becoming an increasingly recognised entity. We aimed to describe the characteristics and outcome of patients with PAC presenting to Middlemore Hospital.

A. Kueh, J. Bradley, T. Sutton, R. Gabriel, M. Lund, J. Looi
Counties Manukau District Health, Auckland
Heart, Lung and Circulation – Volume 23, Supplement 1, e1-e48
Abstract & full-text available.

Acute coronary syndrome with non obstructive coronary angiography; Rates, treatment, and outcomes at Middlemore Hospital

Myocardial infarction with non obstructive coronary arteries (MINOCA) describes a heterogeneous subset of acute coronary syndrome (ACS) comprised of proven infarction, myocarditis, pericarditis, cardiomyopathy, and those with normal investigations. Internationally MINOCA accounts for ∼13% of ACS. Previously held as benign, MINOCA increases risk of death and MI. Internationally, fewer patients receive standard ACS treatments. We aim to characterise MINOCA rate, features, treatment and outcome.

P. Barr, A. Kerr
Middlemore Hospital Cardiology, Auckland
Heart, Lung and Circulation – Volume 23, Supplement 1, e1-e48
Abstract & full-text available.

Cases of mitogenic cardiomyopathy in the United Kingdom

International Clinical Cardiovascular Genetics Conference, Brisbane 6-8 August 2014
Published in Heart, Lung and Circulation – Volume 23, Supplement 2, e1-e20
Abstract & full-text available.

Mitogenic cardiomyopathy (MC) is a rare, recessive form of Dilated Cardiomyopathy usually lethal in early infancy. This has been reported in five patients in Canada and characteristic histological features include myocyte hyperplasia and marked mitotic activity (Chang et al., 2010).

Interested in joining CSANZ?